Staff Directory Contact Us

The Nathan S. Kline Institute for Psychiatric Research

new lab building
New and Better Ways to Prevent, Detect and Treat Psychiatric Disorders
Lab bench
New and Better Ways to Prevent, Detect and Treat Psychiatric Disorders
MRI Cropped
New and Better Ways to Prevent, Detect and Treat Psychiatric Disorders
Lakatos 2 Cropped
New and Better Ways to Prevent, Detect and Treat Psychiatric Disorders
New and Better Ways to Prevent, Detect and Treat Psychiatric Disorders
New and Better Ways to Prevent, Detect and Treat Psychiatric Disorders
New and Better Ways to Prevent, Detect and Treat Psychiatric Disorders

The Nathan S. Kline Institute for Psychiatric Research (NKI)

investigates the causes, treatment, prevention, and rehabilitation of severe and persistent mental illnesses. Founded in 1952, NKI has earned a reputation for landmark contributions in the areas of psychopharmacological treatments for schizophrenia and major mood disorders, dementia research, clinical trials methodology, therapeutic drug monitoring, and the application of computer technology to mental health services.

Research

Our research encompasses understanding psychiatric disorders through studies in neurogenetics and neurochemistry; functional brain imaging across the lifespan; evaluating cognition deficits in schizophrenia; understanding the molecular and cellular basis of Alzheimer’s disease; early intervention for people at high risk; and culturally competent care.
Read More

Director’s Message

Our focus is to diminish the impact of psychiatric illness by changing the landscape of brain health, and adding to the knowledge base — from genes and neurons, to drugs and receptors, to cultural understanding.
Read More

News

New research from the lab of Paul Mathews, PhD, part of NKI’s Center for Dementia Research, indicates a link between diabetes and Alzheimer’s disease. The study, which appears in the Journal of Neuroscience, examined the brains of diabetic monkeys and found insulin resistance and other changes consistent with early events in the brain that may predispose people to Alzheimer’s disease. This research was reported in Alzforum.